Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO

Affiliations

Comment

Tatsuki Uemura. JAMA. 2022.

. 2022 May 17;327(19):1928.

doi: 10.1001/jama.2022.5040.

¹ Department of Emergency Medicine and Critical Care, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

No abstract available

Comment in

Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO-Reply.
Levy B, Combes A, Girerd N. Levy B, et al. JAMA. 2022 May 17;327(19):1928-1929. doi: 10.1001/jama.2022.5046. JAMA. 2022. PMID: 35579643 No abstract available.

Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.
Levy B, Girerd N, Amour J, Besnier E, Nesseler N, Helms J, Delmas C, Sonneville R, Guidon C, Rozec B, David H, Bougon D, Chaouch O, Walid O, Hervé D, Belin N, Gaide-Chevronnay L, Rossignol P, Kimmoun A, Duarte K, Slutsky AS, Brodie D, Fellahi JL, Ouattara A, Combes A; HYPO-ECMO Trial Group and the International ECMO Network (ECMONet). Levy B, et al. JAMA. 2022 Feb 1;327(5):442-453. doi: 10.1001/jama.2021.24776. JAMA. 2022. PMID: 35103766 Free PMC article. Clinical Trial.